These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35776395)

  • 1. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma.
    Hua N; Chen A; Yang C; Dong H; He X; Ru G; Tong X; Zhou F; Wang S
    Mol Biol Rep; 2022 Aug; 49(8):7911-7919. PubMed ID: 35776395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.
    Son Y; Shin NR; Kim SH; Park SC; Lee HJ
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8
    Guo M; Yuan F; Qi F; Sun J; Rao Q; Zhao Z; Huang P; Fang T; Yang B; Xia J
    J Transl Med; 2020 Aug; 18(1):306. PubMed ID: 32762721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
    Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
    Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma.
    Yang C; Qian Q; Zhao Y; Huang B; Chen R; Gong Q; Ji H; Wang C; Xia L; You Z; Zhang J; Chen X
    Front Immunol; 2023; 14():1112672. PubMed ID: 36993960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma.
    Yao XM; Zhang FH; Liu Y
    Bull Exp Biol Med; 2023 Apr; 174(6):774-778. PubMed ID: 37162630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.
    Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E
    Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism.
    Liu TY; Yan JS; Li X; Xu L; Hao JL; Zhao SY; Hu QL; Na FJ; Li HM; Zhao Y; Zhao MF
    J Exp Clin Cancer Res; 2024 Aug; 43(1):213. PubMed ID: 39085849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Serum FGL1 as Diagnostic Markers for HBV-Related Hepatocellular Carcinoma.
    Cai X; Tang D; Chen J; Li H; Zhang P
    Lab Med; 2023 May; 54(3):270-281. PubMed ID: 36219698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti-Lag-3 via reducing FGL1 expression.
    Wang J; Wei W; Tang Q; Lu L; Luo Z; Li W; Lu Y; Pu J
    Cancer Med; 2020 Oct; 9(19):7125-7136. PubMed ID: 32810392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
    Jiang SS; Weng DS; Wang QJ; Pan K; Zhang YJ; Li YQ; Li JJ; Zhao JJ; He J; Lv L; Pan QZ; Xia JC
    J Transl Med; 2014 Sep; 12():273. PubMed ID: 25260879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma.
    Yan Q; Lin HM; Zhu K; Cao Y; Xu XL; Zhou ZY; Xu LB; Liu C; Zhang R
    Front Oncol; 2022; 12():810269. PubMed ID: 35273912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma.
    Lin M; He J; Zhang X; Sun X; Dong W; Zhang R; Xu Y; Lv L
    J Clin Invest; 2023 May; 133(9):. PubMed ID: 37115693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.